Cargando…

Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection

BACKGROUND: Immunoscore have shown a promising prognostic value in many cancers. We aimed to establish and validate an immune classifier to predict survival after curative resection of hepatocellular carcinoma (HCC) patients who have undergone curative resection. METHODS: The immunohistochemistry (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wei-Ren, Tian, Meng-Xin, Tang, Zheng, Fang, Yuan, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Tao, Chen-Yang, Zhou, Pei-Yun, Qu, Wei-Feng, Ding, Zhen-Bin, Peng, Yuan-Fei, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341807/ https://www.ncbi.nlm.nih.gov/pubmed/32376890 http://dx.doi.org/10.1038/s41416-020-0864-0

Ejemplares similares

Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis
por: Liu, Wei-Ren, et al.
Publicado: (2020)

Age-adjusted Charlson Comorbidity Index predicts survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Qu, Wei-Feng, et al.
Publicado: (2020)

CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation
por: Shan, Quan-yuan, et al.
Publicado: (2019)

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma
por: Li, Tao, et al.
Publicado: (2016)

Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma
por: Tan, Xiao-ping, et al.
Publicado: (2022)

Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection
por: Lin, Yen-Po, et al.
Publicado: (2021)

Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis
por: Zhou, Pei-Yun, et al.
Publicado: (2017)

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection
por: Zhou, Yan-Ming, et al.
Publicado: (2015)

Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection
por: Wu, Jiong, et al.
Publicado: (2017)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I–III patients with colorectal cancer after operation
por: Xu, Guozeng, et al.
Publicado: (2018)

Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
por: Zhu, Gui‐Qi, et al.
Publicado: (2021)

Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
por: Wu, LinWei, et al.
Publicado: (2012)

Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection
por: Qu, Zhen, et al.
Publicado: (2022)

Additional gastrectomy in early-stage gastric cancer after non-curative endoscopic resection: a meta-analysis
por: Nie, Run-Cong, et al.
Publicado: (2019)

Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection
por: Byeon, Jangmoo, et al.
Publicado: (2012)

Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection
por: Chen, Fei-Yu, et al.
Publicado: (2020)

The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
por: Chen, Yu-Syuan, et al.
Publicado: (2022)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
por: Tian, Meng-Xin, et al.
Publicado: (2019)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015)

Factors influencing early recurrence of hepatocellular carcinoma after curative resection
por: Zhu, Yu, et al.
Publicado: (2020)

Microwave Ablation of Recurrent Hepatocellular Carcinoma after Curative Surgical Resection
por: Adwan, Hamzah, et al.
Publicado: (2023)

Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection
por: Zhu, Bao-Yan, et al.
Publicado: (2019)

Concurrent Cholecystectomy Is Associated with a Lower Risk of Recurrence after Curative Resection in Early-Stage Hepatocellular Carcinoma: A 10 Year Observational Single-Center Study
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

The patterns and timing of recurrence after curative resection for gastric cancer in China
por: Liu, Dan, et al.
Publicado: (2016)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
por: Xu, Wei, et al.
Publicado: (2020)

Higher Risk of Tumor Recurrence in NASH-Related Hepatocellular Carcinoma Following Curative Resection
por: Chien, Shih-Chieh, et al.
Publicado: (2022)

Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma
por: Yang, Shih-Yu, et al.
Publicado: (2021)

An exploration of immunohistochemistry-based prognostic markers in patients undergoing curative resections for colon cancer
por: Bennedsen, Astrid Louise Bjørn, et al.
Publicado: (2022)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
por: Ma, Hui, et al.
Publicado: (2021)

Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
por: Jeon, Mi Young, et al.
Publicado: (2019)

Prognostic Nomograms for Patients with Hepatocellular Carcinoma After Curative Hepatectomy, with a Focus on Recurrence Timing and Post-Recurrence Management
por: Xu, Wei, et al.
Publicado: (2020)

Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection
por: Liao, Rui, et al.
Publicado: (2022)

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection
por: Shu, Qing‐Hua, et al.
Publicado: (2016)

Using immunohistochemistry to classify the molecular subtypes of Paget's disease of the breast
por: Cai, Yujiao, et al.
Publicado: (2023)

Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018)

A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections
por: Tian, Lu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e1tblp1gihf4oe2iv0ua7km88s